Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

Denver Emergency Department HIV Research Consortium

Research output: Contribution to journalArticle

Abstract

Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.

Original languageEnglish (US)
Pages (from-to)599-603
Number of pages5
JournalJournal of Acquired Immune Deficiency Syndromes
Volume68
Issue number5
DOIs
StatePublished - Apr 15 2015

Fingerprint

HIV
Centers for Disease Control and Prevention (U.S.)
Infection

Keywords

  • Denver HIV Risk Score
  • epidemiology
  • HIV infection
  • risk
  • screening
  • targeted
  • validation

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Brief report : Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort. / Denver Emergency Department HIV Research Consortium.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 68, No. 5, 15.04.2015, p. 599-603.

Research output: Contribution to journalArticle

@article{ab1799a373f74f7bbca6511ef3248a56,
title = "Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort",
abstract = "Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6{\%} newly diagnosed infections were identified. Of all visits, 9{\%} were very low risk (HIV prevalence 0.20{\%}), 27{\%} low risk (HIV prevalence 0.17{\%}), 41{\%} moderate risk (HIV prevalence 0.39{\%}), 17{\%} high risk (HIV prevalence 1.19{\%}), and 6{\%} very high risk (HIV prevalence 3.57{\%}). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.",
keywords = "Denver HIV Risk Score, epidemiology, HIV infection, risk, screening, targeted, validation",
author = "{Denver Emergency Department HIV Research Consortium} and Haukoos, {Jason S.} and Emily Hopkins and Bucossi, {Meggan M.} and Lyons, {Michael S.} and Richard Rothman and White, {Douglas A E} and Al-Tayyib, {Alia A.} and Lucy Bradley-Springer and Campbell, {Jonathan D.} and Sabel, {Allison L.} and Thrun, {Mark W.}",
year = "2015",
month = "4",
day = "15",
doi = "10.1097/QAI.0000000000000518",
language = "English (US)",
volume = "68",
pages = "599--603",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Brief report

T2 - Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort

AU - Denver Emergency Department HIV Research Consortium

AU - Haukoos, Jason S.

AU - Hopkins, Emily

AU - Bucossi, Meggan M.

AU - Lyons, Michael S.

AU - Rothman, Richard

AU - White, Douglas A E

AU - Al-Tayyib, Alia A.

AU - Bradley-Springer, Lucy

AU - Campbell, Jonathan D.

AU - Sabel, Allison L.

AU - Thrun, Mark W.

PY - 2015/4/15

Y1 - 2015/4/15

N2 - Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.

AB - Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence 0.20%), 27% low risk (HIV prevalence 0.17%), 41% moderate risk (HIV prevalence 0.39%), 17% high risk (HIV prevalence 1.19%), and 6% very high risk (HIV prevalence 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.

KW - Denver HIV Risk Score

KW - epidemiology

KW - HIV infection

KW - risk

KW - screening

KW - targeted

KW - validation

UR - http://www.scopus.com/inward/record.url?scp=84925273749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925273749&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000518

DO - 10.1097/QAI.0000000000000518

M3 - Article

C2 - 25585300

AN - SCOPUS:84925273749

VL - 68

SP - 599

EP - 603

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -